NCT02

• CAT Number: I043745
• CAS Number: 790245-61-3
• Molecular Formula: C17H16N2O2S
• Molecular Weight: 312.39
• Purity: ≥95%
• Synonyms: 2-(6,7-dihydro-5H-cyclopenta[f][1]benzofuran-3-yl)-N-(5-methyl-1,3-thiazol-2-yl)acetamide
• InChI: InChI=1S/C17H16N2O2S/c1-10-8-18-17(22-10)19-16(20)7-13-9-21-15-6-12-4-2-3-11(12)5-14(13)15/h5-6,8-9H,2-4,7H2,1H3,(H,18,19,20)
• InChIKey: IELCYEUTXLYDOV-UHFFFAOYSA-N
• SMILES: CC1=CN=C(S1)NC(=O)CC2=COC3=C2C=C4CCCC4=C3

NCT02（Cat No.:I043745）is a small molecule compound investigated for its potential therapeutic applications in cancer and other diseases. It functions by targeting specific signaling pathways that regulate cell growth, survival, and apoptosis, aiming to inhibit tumor progression and metastasis. NCT02 is primarily studied in preclinical research for its effectiveness in disrupting key molecular processes associated with cancer cell proliferation. With its ability to modulate critical cellular pathways, NCT02 shows promise as a targeted therapy, offering potential benefits in treating various cancers and exploring new approaches in cancer treatment development.